More people worldwide now know their HIV status
(HealthDay)—Three-quarters of patients living with HIV worldwide know their infection status, according to Knowledge Is Power, a new report released Nov. 22 by UNAIDS.
Dec 3, 2018
0
0
(HealthDay)—Three-quarters of patients living with HIV worldwide know their infection status, according to Knowledge Is Power, a new report released Nov. 22 by UNAIDS.
Dec 3, 2018
0
0
Researchers at Johns Hopkins have identified two patients with HIV whose immune cells behave differently than others with the virus and actually appear to help control viral load even years after infection. Moreover, both ...
Nov 27, 2018
0
26
A United Nations initiative backed by global experts has set its sights on an ambitious programme to bring an end to the AIDS epidemic by 2030.
Oct 23, 2018
0
0
Immunotherapy has been a major breakthrough in oncology, with registered drugs now approved for use in an increasing number of tumour types—but little is known about its safety for HIV-positive cancer patients. A study ...
Oct 20, 2018
0
0
Human herpesviruses such as HHV-6 can remain dormant in cells for many years without being noticed. When reactivated, they can cause serious clinical conditions. Researchers from Würzburg have now found a way of differentiating ...
Sep 14, 2018
0
0
A study led by the Kirby Institute at UNSW supports evidence that treatment-as-prevention allows people living with HIV to have effectively zero chance of sexually transmitting the virus to others.
Jul 17, 2018
0
3
Results from a pivotal trial of PRO 140, a new HIV therapy, show that PRO 140 is an effective, long-acting therapeutic in combination with antiretroviral treatment (ART) for previously treated HIV-1 infected patients. This ...
Jun 9, 2018
0
4
(HealthDay)—A lower percentage of blacks than Hispanics and whites with HIV infection have sustained viral suppression, according to research published in the Feb. 2 issue of the U.S. Centers for Disease Control and Prevention's ...
Feb 6, 2018
0
14
A short-term pause in HIV treatment during a carefully monitored clinical trial does not lead to lasting expansion of the HIV reservoir nor cause irreversible damage to the immune system, new findings suggest.
Jan 11, 2018
0
5
Most HIV-positive people in France under treatment take a daily dose of antiviral drugs for life. However, a major trial is currently underway that may confirm that patients could omit several days of treatment a week without ...
Dec 1, 2017
0
0